EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Scope & Guideline

Exploring Breakthroughs in Pathology and Forensic Medicine

Introduction

Immerse yourself in the scholarly insights of EXPERT REVIEW OF MOLECULAR DIAGNOSTICS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1473-7159
PublisherTAYLOR & FRANCIS AS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV MOL DIAGN / Expert Rev. Mol. Diagn.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKARL JOHANS GATE 5, NO-0154 OSLO, NORWAY

Aims and Scopes

The 'Expert Review of Molecular Diagnostics' focuses on advancing the field of molecular diagnostics through comprehensive reviews and analyses of current methodologies, technologies, and applications. The journal emphasizes the integration of innovative diagnostic techniques within clinical settings, aiming to enhance patient outcomes and facilitate personalized medicine.
  1. Molecular Diagnostic Technologies:
    The journal covers a wide array of molecular diagnostic technologies, including next-generation sequencing, PCR, and liquid biopsy methods, emphasizing their applications in various diseases such as cancer, infectious diseases, and genetic disorders.
  2. Biomarker Discovery and Validation:
    A significant focus is placed on the identification and validation of biomarkers that can aid in the diagnosis, prognosis, and treatment response monitoring in various conditions, particularly cancers and chronic diseases.
  3. Point-of-Care Testing:
    The journal highlights the developments in point-of-care testing (POCT) technologies, examining their role in improving accessibility and timeliness of diagnostics, especially in resource-limited settings.
  4. Emerging Infectious Diseases and Diagnostics:
    Research on the molecular diagnostics of emerging infectious diseases is a core area, especially in the context of global health challenges such as the COVID-19 pandemic.
  5. Translational Medicine and Clinical Applications:
    The journal emphasizes the translation of laboratory research into clinical practice, focusing on how molecular diagnostic advancements can be integrated into routine healthcare to improve patient management.
Recent publications in the 'Expert Review of Molecular Diagnostics' have highlighted several emerging themes that reflect the evolving landscape of molecular diagnostics. These trends indicate a shift towards innovative technologies and methodologies that enhance diagnostic capabilities and patient outcomes.
  1. Liquid Biopsy and Non-invasive Diagnostics:
    There is a growing emphasis on the use of liquid biopsies for cancer detection and monitoring, as well as for other diseases, reflecting a trend towards non-invasive diagnostic methods that provide real-time insights into disease status.
  2. Integration of Artificial Intelligence in Diagnostics:
    The incorporation of artificial intelligence and machine learning techniques in diagnostic processes is trending, with studies focusing on improving diagnostic accuracy and efficiency through data-driven approaches.
  3. Multi-Omics Approaches:
    Research is increasingly adopting multi-omics strategies, combining genomics, proteomics, and metabolomics to provide a more comprehensive understanding of disease mechanisms and improve diagnostic precision.
  4. Point-of-Care Innovations:
    There is a notable increase in research related to innovative point-of-care testing solutions, especially in the context of rapid diagnostics for infectious diseases and chronic conditions, highlighting the need for accessible healthcare solutions.
  5. Biomarkers for Personalized Medicine:
    Emerging themes focus on the identification of biomarkers that can guide personalized treatment strategies, particularly in oncology, reflecting a trend towards tailored therapeutic approaches based on individual patient profiles.

Declining or Waning

Over the recent years, certain themes in the field of molecular diagnostics have seen a decline in prominence within the journal's publications. This section outlines these waning themes, reflecting shifts in research focus and emerging priorities.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in publications related to traditional diagnostic methods, such as histopathology and serological testing, as the field increasingly shifts towards molecular and genomic approaches.
  2. Basic Research without Clinical Application:
    Papers focusing solely on basic research without clear clinical implications or applications are becoming less frequent, as the journal prioritizes studies that bridge the gap between research and clinical practice.
  3. Single Biomarker Studies:
    Research centered around single biomarker assessments without a multi-omics or systems biology approach is declining, reflecting a trend towards more comprehensive diagnostic strategies that consider multiple biomarkers and pathways.
  4. Static Diagnostic Technologies:
    The exploration of static or outdated diagnostic technologies is waning, as the field moves towards innovative, dynamic, and high-throughput technologies that can provide better diagnostics.
  5. Non-integrative Studies:
    There is a decrease in studies that do not integrate molecular diagnostics with other clinical data or advanced analytics, as the trend is moving towards more holistic and integrative approaches to patient diagnostics.

Similar Journals

Biomarkers in Medicine

Innovating the Future of Medical Biochemistry
Publisher: FUTURE MEDICINE LTDISSN: 1752-0363Frequency: 24 issues/year

Biomarkers in Medicine is a prominent academic journal dedicated to advancing the field of medical biochemistry and drug discovery. Published by Future Medicine Ltd in the United Kingdom, this journal aims to provide a platform for researchers, clinicians, and biotechnology professionals to share their findings on the critical role of biomarkers in diagnosis, treatment, and prognosis of various diseases. With a focus on high-quality, peer-reviewed research, Biomarkers in Medicine supports the dissemination of innovative approaches and therapeutic developments across its converged publication years from 2008 to 2024. Rated in the Q3 category for biochemistry (medical), clinical biochemistry, and drug discovery, it occupies a significant place in its field, attracting contributions that push the boundaries of knowledge and application. Although it does not offer open access, the journal remains committed to excellence and rigor in the representation of ground-breaking studies, making it an essential resource for scholars and professionals eager to stay at the forefront of biomarker research.

JOURNAL OF CLINICAL PATHOLOGY

Bridging Laboratory Discoveries with Patient Care
Publisher: BMJ PUBLISHING GROUPISSN: 0021-9746Frequency: 12 issues/year

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

International Journal of Clinical and Experimental Pathology

Bridging Clinical Insights with Experimental Findings
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

Diagnostics

Advancing the Frontiers of Clinical Biochemistry
Publisher: MDPIISSN: Frequency: 12 issues/year

Diagnostics is a pioneering open-access journal published by MDPI, catering to the critical field of clinical biochemistry since its establishment in 2011. Based in Switzerland, this esteemed journal, with E-ISSN 2075-4418, has gained significant recognition within the academic community, reflected in its 2023 Scopus rankings placing it in Q2 for Clinical Biochemistry and showcasing its impact in related medical disciplines. With a commitment to disseminating high-quality research that advances the understanding of diagnostic techniques and methodologies, Diagnostics covers a broad spectrum of topics including biochemical markers, diagnostic imaging, and molecular diagnostics. The journal's open access model ensures that groundbreaking findings are readily available to researchers, professionals, and students alike, fostering an environment of knowledge sharing and collaboration. As the field of diagnostics continues to evolve, Diagnostics remains at the forefront, paving the way for innovations that enhance health outcomes globally.

Asian Biomedicine

Bridging Knowledge Gaps in Biomedical Sciences
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Molecular Genetics & Genomic Medicine

Fostering global dialogue in molecular biology.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

JOURNAL OF CLINICAL LABORATORY ANALYSIS

Connecting global researchers in laboratory medicine.
Publisher: WILEYISSN: 0887-8013Frequency: 9 issues/year

JOURNAL OF CLINICAL LABORATORY ANALYSIS is a premier, peer-reviewed journal published by WILEY, focusing on the expansive field of laboratory medicine. With its ISSN 0887-8013 and E-ISSN 1098-2825, this open access journal has been serving the scientific community since 1987. As of 2023, it holds a notable impact in various domains, achieving category quartiles in Biochemistry, Clinical Biochemistry, Hematology, and more, showcasing its significance across multiple disciplines such as Medical Laboratory Technology and Public Health. Ranked impressively, it is placed 7th in Medical Laboratory Technology, reflecting its crucial role in advancing clinical practice and research. The journal aims to disseminate innovative research findings, methodologies, and reviews that can catalyze advancements in laboratory practices and improve patient outcomes. Accessible to a global audience since its transition to open access in 2019, the journal is not just limited to professionals but is also a valuable resource for students and researchers seeking to stay updated in this dynamic field. For more information, visit the journal's website.

MOLECULAR MEDICINE

Transforming Knowledge into Clinical Solutions
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Empowering Research in Microbiology and Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 0732-8893Frequency: 12 issues/year

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Journal of Laboratory Physicians

Advancing laboratory medicine through collaborative research.
Publisher: THIEME MEDICAL PUBL INCISSN: 0974-2727Frequency: 4 issues/year

The Journal of Laboratory Physicians is a prestigious, peer-reviewed publication dedicated to advancing the field of laboratory medicine. Published by THIEME MEDICAL PUBL INC, this journal has established itself as a vital source of research and clinical insights since its inception, transitioning to Open Access in 2009 to broaden its reach and accessibility. With an ISSN of 0974-2727 and an E-ISSN of 0974-7826, it aims to provide a platform for professionals, researchers, and students engaged in laboratory-based studies to share critical findings and foster collaboration across disciplines. The journal's scope encompasses a wide range of topics relevant to laboratory physicians, ensuring that it remains an essential resource for those seeking to stay on the cutting edge of laboratory practices and innovations. By disseminating timely research and reviews, the Journal of Laboratory Physicians plays a crucial role in enhancing the quality of healthcare through improved laboratory services.